Most popular articles on this site Articles on pharmacy Articles on capitation Articles on disease management

www managedcaremag.com
Click Here



NOW AVAILABLE
The next generation in online publishing...


Sign up to read the digital versions of Managed Care, P&T, and Biotechnology Healthcare. These digital editions are free, searchable, and can be downloaded and read offline. To read a sample of the digital version of Managed Care, follow this link:

> Sample digital edition

> Register for a free digital subscription

Archive issues of Managed Care:


MANAGED CARE December 2002. ©MediMedia USA

Vol. 11, No. 12

Cover Story

Blues Power

Blue Cross and Blue Shield plans have experienced unprecedented success during the last three years. Can they keep it up? And can their success be replicated by other plans?

Malpractice Coverage Crisis Hurts Patients

The growing cost of malpractice coverage has led physicians to leave at least a dozen states, thinning provider panels.

Q&A: Humana's Virtual Strides

Jonathan T. Lord, MD, is exploring and exploiting high-tech ways to engage members in intelligent decision making.

The New Employer Advisory Panels

How better to know customers' needs than to have them meet with company execs to discuss health care delivery issues.

Let Patients Seize the Day

A system called advanced access guarantees same-day appointments. It's easier to implement than you think.

DEPARTMENTS

Editor's Memo

Demonstration projects.

Viewpoint

NCQA defends its role.

News and Commentary

IOM: Fix Health Care's Woes by Using States as Laboratories
Drug-discount program's effectiveness hindered by lack of use
Many Misjudge HMOs' Slice of Premium Pie
California Puts Doctor Scores On Report Cards
Headlines On Deadline ...

Legislation and Regulation

Single-payer push not over.

Ethics

Obesity's venture-tort model.

Compensation Monitor

Capitation in retreat.

Formulary Files

Generic Prilosec.

Legal Forum

Research, marketing, and HIPAA.

Systems & Software

What the vendor doesn't tell you.

Outlook

M+C woes hinder drug access.